TargeGen
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelof Myelofibrosis | Phase 1 | 2008-01-01 |
| Terminated | Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD Macular Degeneration, Choroidal Neovascularization | Phase 2 | 2007-07-01 |
| Completed | A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers Macular Degeneration, Diabetic Retinopathy | Phase 1 | 2006-11-01 |
| Completed | Safety of TG100-115 for Heart Attack Treated With Angioplasty Myocardial Infarction | Phase 1 / Phase 2 | 2005-01-01 |